Patient adherence and persistence with oral anticancer treatment.
about
Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancerAmerican Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care GuidelineFactors influencing adherence to cancer treatment in older adults with cancer: a systematic reviewA tailored nurse coaching intervention for oral chemotherapy adherenceRacial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic reviewOral antineoplastic agents: how do we care about adherence?The role of observational studies in optimizing the clinical management of chronic myeloid leukemiaNew Perspective in the Formulation and Characterization of Didodecyldimethylammonium Bromide (DMAB) Stabilized Poly(Lactic-co-Glycolic Acid) (PLGA) NanoparticlesDeterminants of patient adherence: a review of systematic reviews.Patient Out-of-Pocket Payments for Oral Oncolytics: Results From a 2009 US Claims Data AnalysisA new taxonomy for describing and defining adherence to medicationsAdherence with capecitabine: A population-based analysis based on prescription refill data.Smartphone medication adherence apps: potential benefits to patients and providers.Mobile Application to Promote Adherence to Oral Chemotherapy and Symptom Management: A Protocol for Design and DevelopmentDevelopment of fludarabine formulations in the treatment of chronic lymphocytic leukemia.Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitorsEmerging trends in cancer care: health plans' and pharmacy benefit managers' perspectives on changing care models.Adherence to hormone therapy among women with breast cancerMedication errors in the home: a multisite study of children with cancer.Effect of a structured, active, home-based cancer-treatment program for the management of patients on oral chemotherapyInfluence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancerOptimizing adherence to adjuvant imatinib in gastrointestinal stromal tumor.Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104A nation-wide multicenter 10-year (1999-2008) retrospective clinical study of endocrine therapy for Chinese females with breast cancer.The use of erlotinib in daily practice: a study on adherence and patients' experiences.Ethnic disparities in adherence to breast cancer survivorship surveillance care.Non-adherence to drug therapy and drug acquisition costs in a national population--a patient-based register study.Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology products.Oral anticancer agent medication adherence by outpatientsFactors associated to persistence with hormonal therapy in women with breast cancer.Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerationsSafe handling of oral chemotherapeutic agents in clinical practice: recommendations from an international pharmacy panelTotal gastrectomy increases the incidence of grade III and IV toxicities in patients with gastric cancer receiving adjuvant TS-1 treatment.The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer.Electronic monitoring of medication adherence in early maintenance phase treatment for pediatric leukemia and lymphoma: identifying patterns of nonadherencePatient and plan characteristics affecting abandonment of oral oncolytic prescriptionsImproving outcomes in cancer patients on oral anti-cancer medications using a novel mobile phone-based intervention: study design of a randomized controlled trial.Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer.Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care.Complementary or alternative medicine as possible determinant of decreased persistence to aromatase inhibitor therapy among older women with non-metastatic breast cancer.
P2860
Q24632347-9AE1CC36-7EE4-4D8D-8222-565651D836DFQ26773986-85BE6EE0-524B-47D3-99F4-0DF805FAA8C0Q26850736-7C373276-E33A-474A-8EC0-76E8035D5E77Q27013626-3B436549-8E09-4CA6-B2A6-15AA3F38492FQ28082674-90BF71AE-AA73-4358-9F3B-508982493753Q28082909-7CF36EDB-6197-41E2-8BBE-14B01DBCC443Q28085149-F96CB25F-F5B8-4582-8C74-5670C165862CQ28546279-8E48048A-DF68-46D6-BA1B-D12815AFFA6AQ30541800-393BA74D-91A8-4738-A58D-3EE78B8F1EC8Q30560856-903CB292-88EF-4833-8A57-43716653F155Q31054192-06B148A3-E1ED-491C-BF50-317501C9ABDDQ31140272-A1E8DECF-2E90-4443-91CE-89F1408CF133Q33439579-C5F5954D-BA96-47E7-B6F5-8C9F5B825DD3Q33454095-B5B22AA9-424B-4AEA-883A-B031251715A0Q33573355-30AD7CDE-56D9-466F-92E8-AE1F75B361A2Q33603379-8ABC80D4-1AC9-46D2-8385-A62B910551D4Q33714886-9C034C02-320C-414B-9654-B832CE691785Q33755452-038387BC-2DA4-4526-AD97-B6A2E1F2D716Q33819729-0A1392F3-5332-471E-98C9-891F665FEB47Q33831232-91A3FE9E-1C5F-4152-B449-7E28A32BFCF6Q33874887-B81FB250-68F9-4164-BA74-122D926983FCQ33885999-FD978527-1458-437B-86E8-5A638B87F1CEQ33897610-BF7E4F3D-72F3-49AF-B8CE-F6D957376720Q33921197-DFF720E3-7FA2-497D-85CB-06ABEA6FD2B6Q33948681-C8379980-B90D-437D-BAAE-45902CED7F7AQ34025681-375CC335-F583-4578-BD78-150343381BBEQ34084953-4716D80D-EB46-4622-A3D8-69BB2DD6AEB3Q34101250-91514955-F81F-4AE8-B079-722F46D18DE6Q34293339-9640278B-B853-463B-8BE8-C583FEF43931Q34386558-A15B3503-2605-4E0D-B807-B0E5FB6314ACQ34418437-07DE0E04-2F43-40AC-ABAD-8984BCEC8276Q34459756-ACD7AE1F-5B91-4C62-A95D-65BD5CEA130CQ34493523-98A709B6-F6BC-417D-A331-B3C3E5A037DBQ34736154-CB3D3304-EA9F-4BEA-BCA3-3B6B3CFB0D94Q34884871-C0F9BCC6-7D92-4DBD-A9CE-1639A3DCBB9DQ34974158-D531ECD2-A9D1-4F6D-A057-9F74BD21DB98Q34974434-29085768-8590-46A6-9739-D8EFAE82255FQ35006809-634377C5-2D6E-4997-8AE4-16E008F01281Q35028544-B57D4317-CEB9-477E-957C-169055CA1648Q35075218-754629BC-FF28-45B3-AAE5-D2476273BD3D
P2860
Patient adherence and persistence with oral anticancer treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Patient adherence and persistence with oral anticancer treatment.
@en
Patient adherence and persistence with oral anticancer treatment.
@nl
type
label
Patient adherence and persistence with oral anticancer treatment.
@en
Patient adherence and persistence with oral anticancer treatment.
@nl
prefLabel
Patient adherence and persistence with oral anticancer treatment.
@en
Patient adherence and persistence with oral anticancer treatment.
@nl
P2093
P356
P1433
P1476
Patient adherence and persistence with oral anticancer treatment.
@en
P2093
Ann Partridge
Erica Mayer
Kathryn Ruddy
P356
10.3322/CAAC.20004
P407
P577
2009-01-01T00:00:00Z